SHINE Medical Technologies
About SHINE Medical Technologies
SHINE Medical Technologies™ is dedicated to being the world leader in safe, clean, affordable production of medical tracers and cancer treatment elements. Founded in 2010 to manufacture and sell medical isotopes into an existing global market that serves over 40,000 patients per day in the United States, SHINE anticipates producing enough molybdenum-99 to meet two-thirds of US demand by 2018. With 30 employees and offices in Monona, SHINE has received financial support from angel and venture investors, the Morgridge Institute for Research and the US Department of Energy.